Allergan plc AGN and Gedeon Richter Plc. today announced they will present data on VRAYLAR (cariprazine) in patients with schizophrenia during the 54th American College of Neuropsychopharmacology (ACNP) Annual Meeting in Hollywood Florida, to be held December 6 – 10, 2015.
Logo - http://photos.prnewswire.com/prnh/20150612/222796LOGO
Data to be presented include additional analyses of cariprazine for the potential treatment of predominant negative symptoms in patients with schizophrenia. Also presented will be data investigating the metabolic safety profile of cariprazine and its impact on long-term schizophrenia relapse prevention.
Data Blitz oral presentation given by Rene Kahn
Monday, December 7, 2015, 11:30 a.m.-1:30 p.m. ET, Oral Presentation
Cariprazine as Monotherapy for the Treatment of Predominant Negative Symptoms of Patients with Schizophrenia: A Double-Blind, Active Comparator-Controlled Trial (poster M206) authored by Debelle, M., Nemeth, G., Szalai, E., Szatmari, B., Harsanyi, J., Barabassy, A., Laszlovszky, I., Durgam, S., Fleischhacker, W.W., Kahn, R.
Posters
Monday, December 7, 2015, 5:30-7:30 p.m. ET
Cariprazine as Monotherapy for the Treatment of Predominant Negative Symptoms of Patients with Schizophrenia: A Double-Blind, Active Comparator-Controlled Trial (poster M206) authored by Debelle, M., Nemeth, G., Szalai, E., Szatmari, B., Harsanyi, J., Barabassy, A., Laszlovszky, I., Durgam, S., Fleischhacker, W.W., Kahn, R.
Cariprazine for Negative Symptoms of Schizophrenia: Pooled Post Hoc Analysis of 2 Randomized, Double-Blind, Placebo- and Active-Controlled Trials (poster M204), authored by Earley, W., Durgam, S., Debelle, M., Laszlovszky, I., Lu, K., Nasrallah, H.
Metabolic Safety of Cariprazine in Patients with Schizophrenia (poster M156) authored by Marder, S., Zukin, S., Lu, K., Debelle, M., Durgam, S.
Tuesday, December 8, 2015, 5:30-7:30 p.m. ET
Long-Term Cariprazine Treatment for the Prevention of Relapse in Patients With Schizophrenia: Additional Analysis From a Randomized, Double-Blind, Placebo-Controlled Trial (poster T170), authored by Durgam, S., Earley, W., Li, R., Li, D., Lu, K., Laszlovszky, I., Edwards, J., Nasrallah, H., Fleischhacker, W.W.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in